medications, prior labs, and history/pattern of previous health care utilization. Additional features included demographics, time of day, and date. We utilized gradient boosting (xgBoost), an ensemble machine learning approach, in which a large number of weak learners are iteratively combined together into a single strong learner. 10x cross validation was used for testing. A dashboard for EHR integration was developed to facilitate display of real-time predictions at time of ED presentation.
Study Objectives: Measuring and reporting on process quality measures has become ubiquitous in health care, and the emergency department (ED) is no exception. How well process measures that focus on ED care correlate with subsequent patient outcomes is unclear. We used process measures that were publicly reported to the Centers for Medicare and Medicaid Services Hospital Compare program and sought to determine how performance on those measures correlated with mortality rates.
Methods: We examined the following measures relevant to ED care in 2013-2015 for patients with acute myocardial infarction (AMI): percentage of patients receiving aspirin (ASA) at arrival, percentage of patients receiving primary percutaneous coronary intervention (PCI) within 90 minutes of hospital arrival, median time to ECG for patients with chest pain and median time to transfer to another hospital with for PCI. We grouped hospitals into 3 groups: the bottom 25% of measure performance, the middle 50% of performance and the top 2% of performance. Using linear regression, we calculated risk-adjusted 3-, 7-, 14-, and 30-day mortality rates for ED admissions for AMI among continuously enrolled Medicare beneficiaries age 65 and older using the Medicare inpatient and denominator files from 2013-2015. We incorporated patient age, sex, and chronic conditions as covariates. We ran these models separately for each measure.
Results: The study sample consisted of 4,481 hospitals, of which 54.1% reported on the ASA measure, 54.4% on ECG, 33.9% on PCI, 13.8% on timely transfer for AMI. The mean hospital performance scores for each measure by performance group are presented in Table 1 . When comparing risk-adjusted mortality across these groups we found no significant association between hospital performance on process measures for AMI and patient-level AMI mortality (N¼ 421,795 ED AMI admissions) at any time point for any of the measures (30-day mortality presented in Table 2 ).
Conclusions: We found no evidence that hospitals performing better on most publicly reported ED process measures had better outcomes for patients with AMI. Policymakers should carefully consider if the effort associated with reporting process measures is justified. 
